ELMSFORD, N.Y. & MINNEAPOLIS--(BUSINESS WIRE)--Aug. 4, 2005--BioScrip, Inc. (NASDAQ:BIOS) today reported second quarter 2005 revenue of $286.6 million and a loss per share of $0.10 including special charges totaling $6.6 million ($4.2 million net of taxes), or $0.12 per share. Excluding these charges, earnings per share for the quarter would have been $0.02.
"Our strategy of expanding therapies through our community pharmacies has commenced," stated Henry F. Blissenbach, BioScrip's President and Chief Executive Officer. "We are on track to meet our integration and cost savings targets, with at least $10 million in annual cost savings as we start 2006. However, in the second quarter, we had increased costs as a result of duplicate expenses that were, in fact, planned. We are on track with our first quarter 2006 financial expectations."
